» Authors » Salvatore La Spada

Salvatore La Spada

Explore the profile of Salvatore La Spada including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 30
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Foschi M, DAnna L, De Matteis E, De Santis F, Romoli M, Tassinari T, et al.
Stroke . 2024 Dec; 56(2):305-317. PMID: 39648888
Background: Sex may impact clinical outcomes in patients with stroke treated with dual antiplatelet therapy (DAPT). We aimed to investigate the sex differences in the short-term outcomes of DAPT within...
2.
Ornello R, Foschi M, De Santis F, Romoli M, Tassinari T, Saia V, et al.
Int J Stroke . 2024 Nov; :17474930241302691. PMID: 39558660
Background: According to the literature, about one third of patients with brain ischemic symptoms lasting <24 h, which are classified as Transient ischemic attacks (TIAs) according to the traditional "time-based"...
3.
Foschi M, Ornello R, DAnna L, De Matteis E, De Santis F, Barone V, et al.
Int J Stroke . 2024 Nov; :17474930241302991. PMID: 39555606
Background: Short-term dual antiplatelet treatment (DAPT) is superior to single antiplatelet treatment (SAPT) for secondary prevention in non-cardioembolic minor ischemic stroke and high-risk transient ischemic attack (TIA). As the real-world...
4.
Foschi M, De Matteis E, De Santis F, Romoli M, Tassinari T, Saia V, et al.
J Neurol Sci . 2024 Sep; 466:123211. PMID: 39244893
Background: The outcomes of minor ischemic stroke resulting from small artery occlusion (SAO-MIS) have not yet been characterized after dual antiplatelet treatment (DAPT) has become the standard of care. We...
5.
Ornello R, Foschi M, De Santis F, Romoli M, Tassinari T, Saia V, et al.
J Am Heart Assoc . 2024 Aug; 13(16):e036275. PMID: 39119964
Background: The optimal treatment for acute minor ischemic stroke is still undefined. and options include dual antiplatelet treatment (DAPT), intravenous thrombolysis (IVT), or their combination. We aimed to investigate benefits...
6.
De Matteis E, Ornello R, De Santis F, Foschi M, Romoli M, Tassinari T, et al.
Eur Stroke J . 2024 Jun; 9(4):989-999. PMID: 38869034
Background And Purpose: Randomized controlled trials (RCTs) proved the efficacy of short-term dual antiplatelet therapy (DAPT) in secondary prevention of minor ischemic stroke or high-risk transient ischemic attack (TIA). We...
7.
De Matteis E, De Santis F, Ornello R, Censori B, Puglisi V, Vinciguerra L, et al.
Stroke . 2023 Mar; 54(5):1172-1181. PMID: 36951052
Background: Randomized controlled trials (RCTs) proved that short-term (21-90 days) dual antiplatelet therapy (DAPT) reduces the risk of early ischemic recurrences after a noncardioembolic minor stroke or high-risk transient ischemic...
8.
Marangi G, Lattante S, Doronzio P, Conte A, Tasca G, Monforte M, et al.
Neurobiol Aging . 2016 Dec; 49:218.e1-218.e7. PMID: 28029397
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorder characterized by loss of motor neurons in the primary motor cortex, brainstem, and spinal cord. Recently, missense variants in MATR3 were identified...
9.
Spagnolo F, Nozzoli C, Rini A, La Spada S, De Marco V, Passarella B
J Stroke Cerebrovasc Dis . 2016 Jun; 25(9):e148-50. PMID: 27282303
Scleromyxedema is a rare disease of unknown etiology primarily affecting the skin, characterized by generalized papular eruption, dermal fibroblast proliferation with mucin deposition, and a monoclonal gammopathy. Neurological impairment is...